Literature DB >> 19294426

Intellectual and motor performance, quality of life and psychosocial adjustment in children with cystinosis.

Francis F Ulmer1, Markus A Landolt, Russia Ha Vinh, Thierry A G M Huisman, Thomas J Neuhaus, Bea Latal, Guido F Laube.   

Abstract

Cystinosis is a rare multisystemic progressive disorder mandating lifelong medical treatment. Knowledge on the intellectual and motor functioning, health-related quality of life and psychosocial adjustment in children with cystinosis is limited. We have investigated nine patients (four after renal transplantation) at a median age of 9.7 years (range 5.3-19.9 years). Intellectual performance (IP) was analysed with the Wechsler Intelligence Scale for Children-III (seven children) and the Kaufman Assessment Battery for Children (two children). Motor performance (MP) was evaluated using the Zurich Neuromotor Assessment Test, and quality of life (QOL) was studied by means of the Netherlands Organization for Applied Scientific Research Academical Medical Center Child Quality of Life Questionnaire. Psychosocial adjustment was assessed by the Child Behavior Checklist. The overall intelligence quotient (IQ) of our patient cohort (median 92, range 71-105) was significantly lower than that of the healthy controls (p = 0.04), with two patients having an IQ < 85. Verbal IQ (93, range 76-118) was significantly higher than performance IQ (90, range 68-97; p = 0.03). The MP was significantly below the norm for pure motor, pegboard and static balance, as well as for movement quality. The patients' QOL was normal for six of seven dimensions (exception being positive emotions), whereas parents reported significant impairment in positive emotions, autonomy, social and cognitive functions. Significant disturbance was noted in terms of psychosocial adjustment. Based on the results from our small patient cohort, we conclude that intellectual and motor performance, health-related QOL and psychosocial adjustment are significantly impaired in children and adolescents with cystinosis.

Entities:  

Mesh:

Year:  2009        PMID: 19294426     DOI: 10.1007/s00467-009-1149-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  37 in total

1.  Family impact greatest: predictors of quality of life and psychological adjustment in pediatric burn survivors.

Authors:  Markus A Landolt; Sandra Grubenmann; Martin Meuli
Journal:  J Trauma       Date:  2002-12

2.  Report of an NIH task force on research priorities in chronic kidney disease in children.

Authors:  Russell W Chesney; Eileen Brewer; Marva Moxey-Mims; Sandra Watkins; Susan L Furth; William E Harmon; Richard N Fine; Ronald J Portman; Bradley A Warady; Isidro B Salusky; Craig B Langman; Debbie Gipson; Peter Scheidt; Harold Feldman; Frederick J Kaskel; Norman J Siegel
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

3.  Behavioral profiles of children with infantile nephropathic cystinosis.

Authors:  Gustavo Delgado; Amy Schatz; Sharon Nichols; Mark Appelbaum; Doris Trauner
Journal:  Dev Med Child Neurol       Date:  2005-06       Impact factor: 5.449

4.  Neurobehavioral consequences of a genetic metabolic disorder: visual processing deficits in infantile nephropathic cystinosis.

Authors:  A O Ballantyne; D A Trauner
Journal:  Neuropsychiatry Neuropsychol Behav Neurol       Date:  2000-10

5.  Long-term outcome of paediatric patients with hereditary tubular disorders.

Authors:  D Haffner; A Weinfurth; F Manz; H Schmidt; H J Bremer; O Mehls; K Schärer
Journal:  Nephron       Date:  1999       Impact factor: 2.847

6.  Renal transplantation in 22 children with nephropathic cystinosis.

Authors:  J H Ehrich; J Brodehl; D I Byrd; S Hossfeld; P F Hoyer; K P Leipert; G Offner; G Wolff
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

7.  Immunolocalization of cystinosin, the protein defective in cystinosis.

Authors:  Mushfequr R Haq; Vasiliki Kalatzis; Marie-Claire Gubler; Margaret M Town; Corinne Antignac; William G Van't Hoff; Adrian S Woolf
Journal:  J Am Soc Nephrol       Date:  2002-08       Impact factor: 10.121

8.  Clinical polymorphism of cystinosis encephalopathy. Results of treatment with cysteamine.

Authors:  M Broyer; M J Tête; G Guest; J P Berthélémé; F Labrousse; M Poisson
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

9.  Psychosocial and intellectual development in 12 patients with infantile nephropathic cystinosis.

Authors:  G Wolff; J H Ehrich; G Offner; J Brodehl
Journal:  Acta Paediatr Scand       Date:  1982-11

10.  Improved neurological outcome in children with chronic renal disease from infancy.

Authors:  A Elzouki; J Carroll; D Butinar; A Moosa
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

View more
  8 in total

1.  Cognition in nephropathic cystinosis: pattern of expression in heterozygous carriers.

Authors:  Stephen Niemiec; Angela Ballantyne; Doris A Trauner
Journal:  Am J Med Genet A       Date:  2012-07-11       Impact factor: 2.802

Review 2.  The start of the transplant journey: referral for pediatric solid organ transplantation.

Authors:  Diana Shellmer; Cheryl Brosig; Jo Wray
Journal:  Pediatr Transplant       Date:  2014-01-20

3.  Executive function in nephropathic cystinosis.

Authors:  Angela O Ballantyne; Amy M Spilkin; Doris A Trauner
Journal:  Cogn Behav Neurol       Date:  2013-03       Impact factor: 1.600

4.  Burden of Illness in Acid Sphingomyelinase Deficiency: A Retrospective Chart Review of 100 Patients.

Authors:  Gerald F Cox; Lorne A Clarke; Roberto Giugliani; Margaret M McGovern
Journal:  JIMD Rep       Date:  2018-07-12

5.  Neurocognitive functioning in school-aged cystinosis patients.

Authors:  M T P Besouw; G M Hulstijn-Dirkmaat; R E A van der Rijken; E A M Cornelissen; C M van Dael; J Vande Walle; M R Lilien; E N Levtchenko
Journal:  J Inherit Metab Dis       Date:  2010-09-03       Impact factor: 4.982

6.  Neuropsychological and neuroanatomical phenotype in 17 patients with cystinosis.

Authors:  Aurore Curie; Nathalie Touil; Ségolène Gaillard; Damien Galanaud; Nicolas Leboucq; Georges Deschênes; Denis Morin; Fanny Abad; Jacques Luauté; Eurielle Bodenan; Laurent Roche; Cécile Acquaviva; Christine Vianey-Saban; Pierre Cochat; François Cotton; Aurélia Bertholet-Thomas
Journal:  Orphanet J Rare Dis       Date:  2020-02-26       Impact factor: 4.123

7.  Assessing the integrity of auditory processing and sensory memory in adults with cystinosis (CTNS gene mutations).

Authors:  Ana A Francisco; Alaina S Berruti; Frederick J Kaskel; John J Foxe; Sophie Molholm
Journal:  Orphanet J Rare Dis       Date:  2021-04-13       Impact factor: 4.123

Review 8.  Patient and observer reported outcome measures to evaluate health-related quality of life in inherited metabolic diseases: a scoping review.

Authors:  Carlota Pascoal; Sandra Brasil; Rita Francisco; Dorinda Marques-da-Silva; Agnes Rafalko; Jaak Jaeken; Paula A Videira; Luísa Barros; Vanessa Dos Reis Ferreira
Journal:  Orphanet J Rare Dis       Date:  2018-11-28       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.